These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 2137611)

  • 21. Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat.
    Bohan CA; Robinson RA; Luciw PA; Srinivasan A
    Virology; 1989 Oct; 172(2):573-83. PubMed ID: 2800338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
    Laspia MF; Rice AP; Mathews MB
    Genes Dev; 1990 Dec; 4(12B):2397-408. PubMed ID: 2149119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates.
    Golub EI; Li GG; Volsky DJ
    J Virol; 1990 Aug; 64(8):3654-60. PubMed ID: 2370677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Twu JS; Chu K; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens.
    Thierry F; Heard JM; Dartmann K; Yaniv M
    J Virol; 1987 Jan; 61(1):134-42. PubMed ID: 3023691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.
    Song CZ; Loewenstein PM; Green M
    J Virol; 1995 May; 69(5):2907-11. PubMed ID: 7707515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1.
    Barry PA; Pratt-Lowe E; Peterlin BM; Luciw PA
    J Virol; 1990 Jun; 64(6):2932-40. PubMed ID: 2159554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.
    Kuppuswamy M; Subramanian T; Srinivasan A; Chinnadurai G
    Nucleic Acids Res; 1989 May; 17(9):3551-61. PubMed ID: 2542902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.
    Dasgupta P; Saikumar P; Reddy CD; Reddy EP
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8090-4. PubMed ID: 2236022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation.
    Kalvakolanu DV; Bandyopadhyay SK; Harter ML; Sen GC
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7459-63. PubMed ID: 1652751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.
    Laspia MF; Rice AP; Mathews MB
    Cell; 1989 Oct; 59(2):283-92. PubMed ID: 2553266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus X gene can transactivate heterologous viral sequences.
    Twu JS; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2046-50. PubMed ID: 2538828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5' long terminal repeat.
    Mallon R; Borkowski J; Albin R; Pepitoni S; Schwartz J; Kieff E
    J Virol; 1990 Dec; 64(12):6282-5. PubMed ID: 2173793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site.
    Morris GF; Mathews MB
    J Virol; 1991 Dec; 65(12):6397-406. PubMed ID: 1682506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoregulation of adenovirus E1A gene expression.
    Tibbetts C; Larsen PL; Jones SN
    J Virol; 1986 Mar; 57(3):1055-64. PubMed ID: 2936896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional and transforming activities of the adenovirus E1A proteins.
    Shenk T; Flint J
    Adv Cancer Res; 1991; 57():47-85. PubMed ID: 1835254
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6.
    Martin ME; Nicholas J; Thomson BJ; Newman C; Honess RW
    J Virol; 1991 Oct; 65(10):5381-90. PubMed ID: 1654446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of the adenovirus E2 promoter by simian virus 40 T antigen or E1A occurs by different mechanisms.
    Loeken MR; Khoury G; Brady J
    Mol Cell Biol; 1986 Jun; 6(6):2020-6. PubMed ID: 3023915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.